You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 4, April 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Off-Center Fold
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Diagnosis
 •Wound Healing
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Rapidly Expanding Ulcer—Diagnosis

Arch Dermatol. 2003;139:531-536.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Diagnosis: Myelodysplastic syndrome–associated (paraneoplastic) pyoderma gangrenosum (PG).

MICROSCOPIC FINDINGS AND CLINICAL COURSE

Histologic examination of the skin specimen demonstrated a dense neutrophil-rich interstitial infiltrate of the dermis and subcutaneous tissue, without vasculitis. Significant upper dermal edema and extravasated red blood cells were evident within the epidermis and dermis. The infiltrate did not have atypical features. Special stains and cultures were negative for fungal, mycobacterial, and bacterial organisms. A direct immunofluorescence assay was negative for immunoglobulins and complement deposition. Based on the clinical and immunopathologic features, a diagnosis of PG was made.

High-dose intravenous methylprednisolone therapy (750 mg/m2) was initiated and resulted in marked clinical improvement of the PG lesion. Empirical antibiotic therapy was also administered during this period. The patient's lower extremity pain was treated with a patient-controlled analgesic regimen. She was also receiving etoposide and cyclophosphamide for her chronic myelomonocytic leukemia. The ulcer had healed well, with only a few small open areas. One month later, the patient presented with . . . [Full Text of this Article]

DISCUSSION



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

A Rapidly Expanding Ulcer—Quiz Case
Monika Srivastava, Adrienne Rencic, and H. Carlos Nousari
Arch Dermatol. 2003;139(4):531-536.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.